Exactech was issued U.S. Patent No. 12,239,384, further expanding its intellectual property portfolio relative to Newton soft tissue balancing technology. This newly granted patent originates from a series of dedicated patent applications that enable the software-driven evolution of the Newton technology, marking a significant advancement toward autonomous, personalized surgical planning.
The new patent builds upon previously awarded patents by leveraging a multitude of technologies to develop, execute and assess a patient-specific surgical protocol. While the patent uses a knee-centric workflow, the intellectual property applies to all joints, making the technology adaptable across various partial or total joint replacement procedures.
“This patent represents a major milestone in our mission to revolutionize surgical planning through data-driven technologies,” said Laurent Angibaud, Senior Vice President of Advanced Surgical Technologies Development at Exactech. “Newton empowers surgeons by seamlessly integrating anatomical landmarks, dynamic joint alignment and laxity acquisitions, and real-time adjustments. This advanced technology is poised to make a significant impact by expanding its abilities to deliver personalized, patient-specific planning across all joints.”
This achievement strengthens Exactech’s portfolio of nearly 50 patents dedicated to advancing soft tissue management. Powered by Active Intelligence, the Newton Knee technique integrates with the GPS system to deliver dynamic soft tissue analytics, pre-resection insights and full-range personalized planning for balanced total joint replacement surgery.
Exactech was issued U.S. Patent No. 12,239,384, further expanding its intellectual property portfolio relative to Newton soft tissue balancing technology. This newly granted patent originates from a series of dedicated patent applications that enable the software-driven evolution of the Newton technology, marking a significant advancement toward...
Exactech was issued U.S. Patent No. 12,239,384, further expanding its intellectual property portfolio relative to Newton soft tissue balancing technology. This newly granted patent originates from a series of dedicated patent applications that enable the software-driven evolution of the Newton technology, marking a significant advancement toward autonomous, personalized surgical planning.
The new patent builds upon previously awarded patents by leveraging a multitude of technologies to develop, execute and assess a patient-specific surgical protocol. While the patent uses a knee-centric workflow, the intellectual property applies to all joints, making the technology adaptable across various partial or total joint replacement procedures.
“This patent represents a major milestone in our mission to revolutionize surgical planning through data-driven technologies,” said Laurent Angibaud, Senior Vice President of Advanced Surgical Technologies Development at Exactech. “Newton empowers surgeons by seamlessly integrating anatomical landmarks, dynamic joint alignment and laxity acquisitions, and real-time adjustments. This advanced technology is poised to make a significant impact by expanding its abilities to deliver personalized, patient-specific planning across all joints.”
This achievement strengthens Exactech’s portfolio of nearly 50 patents dedicated to advancing soft tissue management. Powered by Active Intelligence, the Newton Knee technique integrates with the GPS system to deliver dynamic soft tissue analytics, pre-resection insights and full-range personalized planning for balanced total joint replacement surgery.
Copy to clipboard 
